Ovid Therapeutics (OVID) Earnings Date & Reports

Ovid Therapeutics Inc is a biopharmaceutical company that is dedicated to reducing seizures and meaningfully improving the lives of people affected by rare epilepsies and seizure-related neurological disorders... Show more

Industry: #Pharmaceuticals Major

Get AI intraday signals

A.I. Advisor

published Earnings

OVID is expected to report earnings to rise 9.75% to -8 cents per share on November 11

Ovid Therapeutics OVID Stock Earnings Reports

Q3'26

Est.

$-0.09

Q2'26

Beat

by $0.04

Q1'26

Est.

$-0.12

Q4'25

Beat

by $0.17

Q3'25

Missed

by $0.02

The last earnings report on August 13 showed earnings per share of -7 cents, beating the estimate of -11 cents. With 165.89K shares outstanding, the current market capitalization sits at 480.43M.

View a ticker or compare two or three

OVID

Daily Signal:

Gain/Loss:

Interact to see
Advertisement

A.I.Advisor

published price charts

View AI-Driven Trading for OVID